Telomerase activity and htert mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas

International Journal of Cancer

Volumn 98, Issue 6, 2002, Pages 851-856

  Yan, Pu ^a   Benhattar, Jean ^a   Coindre, Jean Michel ^b   Guillou, Louis ^a  

^a UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^b INSTITUT BERGONIÉ   (France)

Author keywords

hTERT; Sarcomas; Soft tissue neoplasms; Telomerase; Telomere; Telomere length; TRAP assay

Indexed keywords

MESSENGER RNA; RNA DIRECTED DNA POLYMERASE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CARCINOGENESIS; CELL HETEROGENEITY; CELL IMMORTALIZATION; CHILD; CLINICAL ARTICLE; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; TELOMERE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARCOMA; SOFT TISSUE NEOPLASMS; TELOMERASE; TELOMERE; TRANSCRIPTION, GENETIC;

EID: 0037140078     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10285     Document Type: Article

References (46)

1. Telomerase: A promising marker of biological immortality of germ, stem and cancer cells. A review
2. A survey of telomerase activity in human cancer
3. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: Correlation with grade, histology and proliferative activity
4. Prognostic significance of telomerase activity in soft tissue sarcomas
5. Telomeric lengths and telomerase activity in liposarcomas
6. High telomerase activity and high HTRT mRNA expression differentiate pure myxoid and myxoid/round-cell liposarcomas
7. Expression of telomerase activity and telomerase RNA in human soft tissue sarcomas
8. Telomerase activity in soft-tissue and bone sarcomas
9. Presence of telomerase activity in different musculoskeletal tumor histotypes and correlation with aggressiveness
10. On telomere shortening in soft-tissue tumors
11. Telomere elongation in immortal human cells without detectable telomerase activity
12. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
13. Alternative lengthening of telomeres in human cells
14. Telomere maintenance by recombination in human cells
15. Telomerase expression shows differences across multiple regions of oligodendroglioma vs. high grade astrocytomas but shows correlation with Mib-1 labeling
16. Focal intratumoral heterogeneity for telomerase activity in human prostate cancer
17. Careful histological confirmation and microdissection reveal telomerase activity in otherwise telomerase-negative breast cancers
18. Histological typing of soft tissue tumors
19. A comparative study of the NCI and FNCLCC grading systems in a population of 410 adult patients with soft tissue sarcoma
20. Tissue quality: An important determinant of telomerase activity as measured by TRAP assay
21. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer
22. Correlation of the expression of human telomerase subunits with telomerase activity in normal skin and skin tumors
23. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity
24. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts
25. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium
26. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types
27. Complex regulation of telomerase activity. Implications for cancer therapy
28. In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis
29. Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues
30. Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues
31. Telomere length in fibroblasts and blood cells from healthy centenarians
32. Rapid telomere shortening in children
33. Telomere shortening in renal cell carcinoma
34. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas
35. Significant telomere shortening in childhood leukemia
36. Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer
37. Dissociation among in vitro telomerase activity, telomere maintenance and cellular immortalization
38. Telomerase activity does not always imply telomere maintenance
39. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids
40. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells
41. Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse
42. Downregulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents
43. Telomere maintenance mechanisms as a target for drug development
44. Molecular targeting of cancer: Telomeres as targets
45. An alternative lifestyle for immortalized oral keratinocytes
46. Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma